Clinical Trials Browser

Active not recruiting × Breast Neoplasms × ibrutinib × Clear all

NCT03379428 2024-12-06

Trial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast Cancer

Phase 1/2 Active not recruiting

Breast Neoplasms